Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Creative Edge Nutrition Inc FITX

Creative Edge Nutrition, Inc. is a nutrition company. The Company is engaged in the development, marketing and sales of nutraceuticals and health supplements. The Company develops, manufactures, markets, distributes, brands and private labels health supplements, energy and fitness products, and bottled water products for the United States and International markets. The Company is involved in the business acceleration, business management and marketing strategies to various international corporations engaged in a range of industries. The Company's products include METABOLIC XTREME, HYPER INFUSION, ALPHA DRIVE, AMINO PLEX, HEMP PLEX, CHIA PLEX, CENTROPLEX, NUTRA TEA and NUTRA COFFEE. It offers a range of capsules, tablets and powders, as well as science-based products in three principal categories: weight management, nutrition challenges, energy and fitness. The Company provides workout plans, nutrition plans and supplement plans.


GREY:FITX - Post by User

Post by TechDriveon Mar 12, 2015 7:18am
621 Views
Post# 23512607

Statement from Health Canada

Statement from Health Canada
Statement from Health Canada

Further to the statement issued on February 20, 2015, Health Canada is issuing the following update:

On February 13, 2015, Health Canada sent a "Notice of Intent to Refuse" to CEN Biotech, Inc. in response to its application for a license to produce under the Marihuana for Medical Purposes Regulations (MMPR).

The MMPR requires that Health Canada give notice to any applicant to whom it intends to refuse a licence. The applicant was provided 20 days to make written representations.

The Department has today notified the company that the decision to reject the application is now final.
https://news.gc.ca/web/article-en.do?nid=947349&tp=1



<< Previous
Bullboard Posts
Next >>